Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
about
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataMonitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaPlasmodium falciparum drug resistance in AngolaMeasuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring DeviceTherapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest EthiopiaArtemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan childrenTherapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern TanzaniaArtemether-lumefantrine: an option for malaria.Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective studyEfficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight rangesRepeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impactPrevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest BeninSequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphismsCost and Predictors of Care-Seeking Behaviors Among Caregivers of Febrile Children-Uganda, 2009.Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, TanzaniaAdding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia.Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Oil-Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum Malaria.Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers.pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.Sustained High Cure Rate of Artemether-Lumefantrine against Uncomplicated Plasmodium falciparum Malaria after 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in ZanzibarAssessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling.Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial.Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo.Semi-quantitative measurement of the antimalarial lumefantrine from untreated dried blood spots using LC-MS/MS.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
P2860
Q26783646-9061EB57-E6FE-4051-A2AF-99C45FD6B72CQ26820807-98762245-365A-49B0-AE33-6F49CE9DCEDDQ28075079-4600B193-53FA-4A8C-809A-B0EB464AF954Q28546804-7CE9616A-312C-40F5-8F6F-499A73A92F05Q33605847-D48F893A-8DA0-49EA-ADA6-196D3EAA4364Q34137766-0B352621-0E38-47F5-9208-1F8F6F9464F4Q34253706-9F179B83-535D-4232-932A-0C0057CD393FQ34267667-B6C3AA71-5944-4D5B-8619-9C066589A8A1Q34728230-44778058-B941-4532-B7BC-E0A7340046ECQ34922694-F77DA447-D120-4731-95FF-74A1322B2D37Q35833995-2D31F0BD-0B60-4FDD-A31B-3E0D1B2ED421Q35834482-0FF165D6-1C0E-47E7-80CF-541B4B54578BQ36080127-D680B506-B67D-4716-BC83-2908C87DA1CEQ36108352-BFAF229C-54F1-4AAE-A07C-CEE958504DF6Q36412071-9D64B736-CB49-43D8-9334-83CCCCB62052Q36489791-F122FA45-9B42-4E17-AC6E-730D8541B7DEQ36526649-056D9D1D-300E-4593-8E78-56A1DEE8B1FEQ36584636-859E4840-36E1-4DBB-978A-40504CA864A6Q36776183-950FD9AB-31E1-4D4D-87B7-2022FF5C7ABCQ37023164-D10583ED-3E8D-4F23-A28B-00283AD4640EQ37038288-EBD534B4-8B5B-4A7D-89CA-21077BE24A80Q37066203-E64AC083-1C1B-4286-B00F-1531A976CE23Q37211878-660F6B1D-0C67-4F76-BDAF-AB021529CEEDQ37217604-0F381DF0-5EC8-4D0C-A1AC-C5F728C03B19Q37279764-0F02C3C5-3764-4ABD-9D8F-1A95A6E6EA46Q38529669-400BC023-6835-4A7D-9F12-196A3B964505Q38852053-2DD5D907-626D-44D9-90EE-9920714C456CQ38865815-3BA119F5-8C2E-4972-B259-81E5E594E1D4Q39206934-9DA3B5F6-65AE-4C56-865C-91DC1FE373BFQ40075427-22ABBFBD-A43B-4855-9680-95BC51F623C6Q41827965-D9B77484-979C-49D0-81E8-46C634190D7BQ43924014-5BB11ECD-83AF-416A-9DAE-F513C91BC69BQ43927844-AB83F98C-0203-49E1-BE08-44DE6E305920Q52615236-4912A0ED-CDDB-449C-AFEE-895937ED0106Q53686432-36AE37E0-64EC-4CC7-A628-598724A91F07Q54235937-4B20F47C-15A1-47FA-BFB6-16098E5F8B9AQ55449589-0E834C18-658D-41EA-AF33-34643EB23631
P2860
Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@en
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@nl
type
label
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@en
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@nl
prefLabel
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@en
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@nl
P2093
P50
P921
P356
P1476
Efficacy and effectiveness of ...... Tanzania: a randomized trial.
@en
P2093
Andreas Mårtensson
Anja M Carlsson
Billy E Ngasala
Daniel Blessborn
Max G Petzold
Yngve Bergqvist
Zul Premji
P304
P356
10.1093/CID/CIR066
P407
P577
2011-04-01T00:00:00Z